Over $3,000 Paid Clinical Trials
440 studies
Extended inpatient Phase 1 studies with longer residential stays or multiple periods may compensate $3,000 or more.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 281–300 of 440 studies
Recruiting
Phase 1
A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects
Targeted TherapyExosomeHealthy Subjects
Shine-On Biomedical Co., Ltd.15 enrolled1 locationNCT07219940
Recruiting
Phase 1
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
HealthyCeliac Disease
Nielsen Fernandez-Becker18 enrolled1 locationNCT07063823
Recruiting
Phase 1
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
Healthy Participants
Latigo Biotherapeutics236 enrolled1 locationNCT07110610
Recruiting
Phase 1
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
Healthy
Latigo Biotherapeutics204 enrolled1 locationNCT06049095
Recruiting
Phase 1
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
healthy adult participants
Jiangsu Simcere Pharmaceutical Co., Ltd.60 enrolled1 locationNCT07357610
Recruiting
Phase 1
A Phase I Study of HW201877 in Healthy Subjects
Healthy ParticipantsIBD (Inflammatory Bowel Disease)
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company104 enrolled1 locationNCT07373457
Recruiting
Phase 1
A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy Participants
Healthy
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)80 enrolled1 locationNCT06977880
Recruiting
Phase 1
A Phase 1 Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)
Healthy ParticipantsPharmacokinetic Study
Angitia Incorporated Limited30 enrolled1 locationNCT07361354
Recruiting
Phase 1
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
HealthyType 1 Diabetes Mellitus
Eli Lilly and Company118 enrolled1 locationNCT06280703
Recruiting
Phase 1
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
Healthy Adult Male and Female Volunteers
Berlin-Chemie AG Menarini Group26 enrolled1 locationNCT07201584
Recruiting
Phase 1
Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes
Healthy Volunteer
Cohen Global, Ltd.54 enrolled1 locationNCT06739707
Recruiting
Phase 1
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
SleepHealthy Participants
Johns Hopkins University20 enrolled1 locationNCT07224074
Recruiting
Phase 1
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Healthy VolunteersCardiac Repolarization
Sanofi44 enrolled2 locationsNCT07272629
Recruiting
Phase 1
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
Healthy Volunteers
AbbVie66 enrolled1 locationNCT07306754
Recruiting
Phase 1
A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
Healthy Adult
Daewon Pharmaceutical Co., Ltd.150 enrolled1 locationNCT07343245
Recruiting
Phase 1
First-in-Human Trial of Oral AN2-502998
Healthy Volunteers
AN2 Therapeutics, Inc72 enrolled1 locationNCT07024589
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Healthy Volunteers
Bristol-Myers Squibb106 enrolled1 locationNCT07283263
Recruiting
Phase 1
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
Healthy SubjectsOverweight Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.111 enrolled1 locationNCT07331389
Recruiting
Phase 1
Study Evaluating Safety of BT01001 Ophthalmic Solution
Healthy
Beyang Therapeutics Co., Ltd.32 enrolled1 locationNCT07313722
Recruiting
Phase 1
Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
HealthyHealthy Participants
Beijing Tide Pharmaceutical Co., Ltd90 enrolled1 locationNCT07301203